迪哲医药: 迪哲医药：关于变更注册资本、修订《公司章程》并办理工商变更登记的公告

Summary of Key Points Core Viewpoint The announcement details the changes in the registered capital and governance structure of Dize Pharmaceutical Co., Ltd., including the cancellation of the supervisory board and amendments to the company's articles of association. Group 1: Changes in Registered Capital - The company completed a private placement of restricted shares on April 18, 2025, increasing the total number of shares by 41.7648 million [1]. - The registered capital increased from RMB 417,648,086 to RMB 459,412,894 [1][2]. Group 2: Cancellation of Supervisory Board - The company will no longer have a supervisory board, with its functions being transferred to the audit committee of the board of directors [1][2]. - This change is in accordance with the Company Law and the revised guidelines for listed companies [1]. Group 3: Amendments to Articles of Association - The company revised its articles of association and related rules, including the shareholder meeting rules and board meeting rules, while abolishing the supervisory board meeting rules [2][3]. - The amendments aim to enhance the governance structure and align with current legal requirements [2][3].